Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study-Reference-Cited by-同舟云学术

Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study

Published:2013-03-13 Issue:5 Volume:133 Page:1204-1213
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Stragliotto Giuseppe¹,Rahbar Afsar²,Solberg Nina Wolmer²,Lilja Anders³,Taher Chato²,Orrego Abiel⁴,Bjurman Birgitta⁵,Tammik Charlotte²,Skarman Petra²,Peredo Inti,Söderberg-Nauclér Cecilia²

Affiliation:

1. Department of Neurology; Karolinska University Hospital; Sweden

2. Department of Medicine; Solna, Center for Molecular Medicine, L8:03, Karolinska Institute; 171 76; Stockholm; Sweden

3. Department of Neuroradiology; Karolinska University Hospital; Sweden

4. Department of Neuropathology; Karolinska University Hospital; Sweden

5. Nurses Supervision and Research, AB; Celsiusgatan 4, 112 30; Stockholm

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009